SCHEMBL4012818

SCHEMBL4012818

Cc1cnc(N)nc1-c1cnco1

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.41
PKM P14618 1/20 0.41
MAP4K4 O95819 1/20 0.37
MAP3K14 Q99558 2/20 0.36
NUDT1 P36639 5/20 0.36
IMPDH2 P12268 1/20 0.36
IMPDH1 P20839 1/20 0.36
PTK2 Q05397 1/20 0.35
KDM5B Q9UGL1 1/20 0.35
GRM4 Q14833 1/20 0.34
CYP11B1 P15538 1/20 0.33
CYP11B2 P19099 1/20 0.33
NOTUM Q6P988 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2D6 P10635 1/20 0.33
HRH4 Q9H3N8 1/20 0.33
GAA P10253 1/20 0.33
ROCK2 O75116 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4012820 0.76 IMPDH2 (0.42) LMNAPKMMAP4K4IMPDH2IMPDH1
SCHEMBL7147816 0.75 ADORA2A (0.52) LMNAPKM
SCHEMBL30463597 0.70 PTK2 (0.52) LMNAPKMMAP4K4IMPDH2IMPDH1
SCHEMBL10936938 0.68 ADORA1 (0.58) LMNAMAP3K14GRM4
SCHEMBL24310606 0.67 FGFR1 (0.50) MAP3K14NUDT1GRM4
SCHEMBL3433303 0.67 HSP90AA1 (0.49) MAP4K4PTK2GRM4NOTUMGAA
SCHEMBL23494350 0.67 HTT (0.41) MAP3K14NUDT1PTK2GRM4
SCHEMBL29430426 0.66 DHFR (0.49) LMNAPKMMAP4K4PTK2CYP11B1
SCHEMBL4471892 0.66 DHFR (0.49) LMNAPKMMAP4K4PTK2CYP11B1
SCHEMBL21121007 0.66 KMT2A (0.47) MAP3K14GRM4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2044063-A1 PYRIMIDINE DERIVATIVES USEFUL IN THE TREATMENT OF CANCER Astra Zeneca AB (SE) 2009-04-08 EP disclosed
WO-2008001070-A1 PYRIMIDINE DERIVATIVES USEFUL IN THE TREATMENT OF CANCER ASTRAZENECA AB (SE) 2008-01-03 WO disclosed